Login / Signup

Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding.

Richard F MacLehoseNeil A ZakaiRob F WalkerAlvaro AlonsoTerrence AdamsPamela L Lutsey
Published in: Research and practice in thrombosis and haemostasis (2021)
We found modest evidence of decreased risk of bleeding for apixaban and rivaroxaban. These estimates were relatively imprecise.
Keyphrases
  • venous thromboembolism
  • atrial fibrillation
  • direct oral anticoagulants
  • palliative care
  • mental health
  • acute care